CN Patent

CN119424427A — 一种新型安全止吐药及其应用

Assigned to Shijiazhuang Anteng Technology Co ltd · Expires 2025-02-14 · 1y expired

What this patent protects

本发明提供了一种新型安全止吐药及其应用。本发明提供的新型安全止吐药为含有5‑羟色胺受体拮抗剂和钾离子通道开放剂的复方制剂，其能有效避免5‑羟色胺受体拮抗剂昂丹司琼引发QT间期延长，减少相应心律失常、心动过速和心源性猝死的可能性。本申请同时提供了钾离子通道开放剂在制备降低QT间期延长的药物中的应用以及相应治疗方法。

USPTO Abstract

本发明提供了一种新型安全止吐药及其应用。本发明提供的新型安全止吐药为含有5‑羟色胺受体拮抗剂和钾离子通道开放剂的复方制剂，其能有效避免5‑羟色胺受体拮抗剂昂丹司琼引发QT间期延长，减少相应心律失常、心动过速和心源性猝死的可能性。本申请同时提供了钾离子通道开放剂在制备降低QT间期延长的药物中的应用以及相应治疗方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN119424427A
Jurisdiction
CN
Classification
—
Expires
2025-02-14
Drug substance claim
No
Drug product claim
No
Assignee
Shijiazhuang Anteng Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.